GSA Capital Partners LLP lifted its stake in Pharmerica Corporation (NYSE:PMC) by 36.9% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,433 shares of the company’s stock after acquiring an additional 3,349 shares during the quarter. GSA Capital Partners LLP’s holdings in Pharmerica Corporation were worth $326,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently made changes to their positions in PMC. SG Americas Securities LLC bought a new stake in shares of Pharmerica Corporation in the first quarter worth approximately $121,000. Russell Investments Group Ltd. grew its stake in shares of Pharmerica Corporation by 124.5% in the second quarter. Russell Investments Group Ltd. now owns 4,886 shares of the company’s stock worth $128,000 after acquiring an additional 2,710 shares during the period. State of Alaska Department of Revenue grew its stake in shares of Pharmerica Corporation by 79.8% in the second quarter. State of Alaska Department of Revenue now owns 6,112 shares of the company’s stock worth $160,000 after acquiring an additional 2,712 shares during the period. US Bancorp DE grew its stake in shares of Pharmerica Corporation by 41.3% in the first quarter. US Bancorp DE now owns 7,121 shares of the company’s stock worth $167,000 after acquiring an additional 2,081 shares during the period. Finally, Mason Street Advisors LLC grew its stake in shares of Pharmerica Corporation by 7.0% in the first quarter. Mason Street Advisors LLC now owns 7,200 shares of the company’s stock worth $168,000 after acquiring an additional 474 shares during the period. Hedge funds and other institutional investors own 92.15% of the company’s stock.
A number of brokerages have recently commented on PMC. Zacks Investment Research lowered shares of Pharmerica Corporation from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. ValuEngine lowered shares of Pharmerica Corporation from a “buy” rating to a “hold” rating in a research note on Friday, September 22nd. Barrington Research lowered shares of Pharmerica Corporation from an “outperform” rating to an “underperform” rating in a research note on Wednesday, August 9th. KeyCorp lowered shares of Pharmerica Corporation to an “overweight” rating in a research note on Tuesday, August 8th. Finally, Credit Suisse Group lowered shares of Pharmerica Corporation from an “outperform” rating to a “neutral” rating and lifted their price target for the stock from $29.00 to $29.25 in a research note on Friday, August 4th. They noted that the move was a valuation call. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company. Pharmerica Corporation presently has an average rating of “Hold” and an average target price of $30.50.
Pharmerica Corporation (NYSE:PMC) opened at 29.15 on Tuesday. Pharmerica Corporation has a 12-month low of $19.20 and a 12-month high of $29.50. The stock has a market cap of $907.18 million, a P/E ratio of 39.50 and a beta of 0.85. The company has a 50 day moving average of $29.15 and a 200-day moving average of $26.46.
Pharmerica Corporation (NYSE:PMC) last posted its quarterly earnings data on Wednesday, August 2nd. The company reported $0.47 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.47. Pharmerica Corporation had a net margin of 1.05% and a return on equity of 10.94%. The firm had revenue of $592.00 million for the quarter, compared to the consensus estimate of $592.96 million. During the same quarter in the prior year, the company posted $0.47 earnings per share. The company’s revenue for the quarter was up 13.9% compared to the same quarter last year. Equities analysts forecast that Pharmerica Corporation will post $1.94 earnings per share for the current year.
WARNING: “Pharmerica Corporation (PMC) Shares Bought by GSA Capital Partners LLP” was first reported by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://transcriptdaily.com/2017/10/17/pharmerica-corporation-pmc-shares-bought-by-gsa-capital-partners-llp.html.
About Pharmerica Corporation
Receive News & Ratings for Pharmerica Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharmerica Corporation and related companies with MarketBeat.com's FREE daily email newsletter.